A predicted binding site for cholesterol on the GABAA receptor

Biophysical Journal

Volumn 106, Issue 9, 2014, Pages 1938-1949

  Hénin, Jérôme ^a   Salari, Reza ^b,c   Murlidaran, Sruthi ^c   Brannigan, Grace ^b,c  

^a France   (France)

^b RUTGERS UNIVERSITY   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CAENORHABDITIS ELEGANS PROTEIN; CHLORIDE CHANNEL; CHOLESTEROL; GLUTAMATE-GATED CHLORIDE CHANNELS; IVERMECTIN; PROTEIN BINDING;

BINDING SITE; CHEMISTRY; ENZYME SPECIFICITY; HUMAN; HYDROGEN BOND; METABOLISM; MOLECULAR DOCKING; MOLECULAR DYNAMICS; POROSITY; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY;

BINDING SITES; CAENORHABDITIS ELEGANS PROTEINS; CHLORIDE CHANNELS; CHOLESTEROL; HUMANS; HYDROGEN BONDING; IVERMECTIN; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; POROSITY; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, GABA-A; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY;

EID: 84899787397     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2014.03.024     Document Type: Article

References (103)

1. A receptors FASEB J. 4 1990 1469 1480
2. A receptor channels Annu. Rev. Neurosci. 17 1994 569 602
3. A receptor research Synapse 21 1995 189 274
4. A receptor mutations associated with generalized epilepsies Adv. Pharmacol. 54 2006 147 169
5. D.A. Lewis, D.W. Volk, and T. Hashimoto Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction Psychopharmacology (Berl.) 174 2004 143 150
6. A receptor γ subunits in the prefrontal cortex of patients with schizophrenia and bipolar disorder Neuroreport 15 2004 1809 1812
7. A receptor β2 gene with schizophrenia Mol. Psychiatry 9 2004 603 608
8. A receptors in aging, Down syndrome and Alzheimer's disease J. Neurochem. 117 2011 613 622
9. A receptor gene locus Proc. Natl. Acad. Sci. USA 99 2002 3729 3733
10. A receptor, are associated with alcohol dependence and with brain oscillations Am. J. Hum. Genet. 74 2004 705 714
11. M.D. Krasowski, and N.L. Harrison General anaesthetic actions on ligand-gated ion channels Cell. Mol. Life Sci. 55 1999 1278 1303
12. K.W. Miller The nature of sites of general anaesthetic action Br. J. Anaesth. 89 2002 17 31
13. H.C. Hemmings Jr.; and M.H. Akabas N.L. Harrison Emerging molecular mechanisms of general anesthetic action Trends Pharmacol. Sci. 26 2005 503 510
14. A-receptor subtypes: a new pharmacology Curr. Opin. Pharmacol. 1 2001 22 25
15. A receptor subtype functions Curr. Opin. Pharmacol. 6 2006 18 23
16. A receptors Psychoneuroendocrinology 34 Suppl 1 2009 S48 S58
17. A receptors: molecular determinants and significance in health and disease Neurochem. Int. 52 2008 588 595
18. A receptor Nat. Rev. Neurosci. 6 2005 565 575
19. A receptors Pharmacol. Ther. 116 2007 35 57
20. A. Miyazawa, Y. Fujiyoshi, and N. Unwin Structure and gating mechanism of the acetylcholine receptor pore Nature 423 2003 949 955
21. N. Unwin Refined structure of the nicotinic acetylcholine receptor at 4 Å resolution J. Mol. Biol. 346 2005 967 989
22. R.J.C. Hilf, and R. Dutzler X-ray structure of a prokaryotic pentameric ligand-gated ion channel Nature 452 2008 375 379
23. J. Pan, and Q. Chen P. Tang Structure of the pentameric ligand-gated ion channel ELIC cocrystallized with its competitive antagonist acetylcholine Nat. Commun. 3 2012 714
24. R.J.C. Hilf, and R. Dutzler Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel Nature 457 2009 115 118
25. N. Bocquet, and H. Nury P.-J. Corringer X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation Nature 457 2009 111 114
26. R.J.C. Hilf, and C. Bertozzi R. Dutzler Structural basis of open channel block in a prokaryotic pentameric ligand-gated ion channel Nat. Struct. Mol. Biol. 17 2010 1330 1336
27. H. Nury, and C. Van Renterghem P.-J. Corringer X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel Nature 469 2011 428 431
28. M.S. Prevost, and L. Sauguet P.-J. Corringer A locally closed conformation of a bacterial pentameric proton-gated ion channel Nat. Struct. Mol. Biol. 19 2012 642 649
29. P.-J. Corringer, and F. Poitevin J.-P. Changeux Structure and pharmacology of pentameric receptor channels: from bacteria to brain Structure 20 2012 941 956
30. M. Jansen, M. Bali, and M.H. Akabas Modular design of Cys-loop ligand-gated ion channels: functional 5-HT3 and GABA ρ1 receptors lacking the large cytoplasmic M3M4 loop J. Gen. Physiol. 131 2008 137 146
31. C.J.B. Dacosta, and J.E. Baenziger Gating of pentameric ligand-gated ion channels: structural insights and ambiguities Structure 21 2013 1271 1283
32. R.E. Hibbs, and E. Gouaux Principles of activation and permeation in an anion-selective Cys-loop receptor Nature 474 2011 54 60
33. T. Lynagh, and J.W. Lynch Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin Front. Mol. Neurosci. 5 2012 60
34. O. Yoluk, and T. Brömstrup E. Lindahl Stabilization of the GluCl ligand-gated ion channel in the presence and absence of ivermectin Biophys. J. 105 2013 640 647
35. N. Calimet, and M. Simoes M. Cecchini A gating mechanism of pentameric ligand-gated ion channels Proc. Natl. Acad. Sci. USA 110 2013 E3987 E3996
36. P. North, and S. Fleischer Alteration of synaptic membrane cholesterol/phospholipid ratio using a lipid transfer protein. Effect on γ-aminobutyric acid uptake J. Biol. Chem. 258 1983 1242 1253
37. M. Criado, H. Eibl, and F.J. Barrantes Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles Biochemistry 21 1982 3622 3629
38. A.W. Dalziel, E.S. Rollins, and M.G. McNamee The effect of cholesterol on agonist-induced flux in reconstituted acetylcholine receptor vesicles FEBS Lett. 122 1980 193 196
39. S.E. Rankin, and G.H. Addona K.W. Miller The cholesterol dependence of activation and fast desensitization of the nicotinic acetylcholine receptor Biophys. J. 73 1997 2446 2455
40. D. Marsh, and F.J. Barrantes Immobilized lipid in acetylcholine receptor-rich membranes from Torpedo marmorata Proc. Natl. Acad. Sci. USA 75 1978 4329 4333
41. O.T. Jones, and M.G. McNamee Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor Biochemistry 27 1988 2364 2374
42. W.S. Leibel, and L.L. Firestone K.W. Miller Two pools of cholesterol in acetylcholine receptor-rich membranes from Torpedo Biochim. Biophys. Acta 897 1987 249 260
43. G. Gimpl, K. Burger, and F. Fahrenholz Cholesterol as modulator of receptor function Biochemistry 36 1997 10959 10974
44. J. Fantini, and F.J. Barrantes Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function Biochim. Biophys. Acta 1788 2009 2345 2361
45. F.J. Barrantes Cholesterol effects on nicotinic acetylcholine receptor J. Neurochem. 103 Suppl 1 2007 72 80
46. C.J.B. daCosta, and A.A. Ogrel J.E. Baenziger Lipid-protein interactions at the nicotinic acetylcholine receptor. A functional coupling between nicotinic receptors and phosphatidic acid-containing lipid bilayers J. Biol. Chem. 277 2002 201 208
47. C.J.B. daCosta, and J.E. Baenziger A lipid-dependent uncoupled conformation of the acetylcholine receptor J. Biol. Chem. 284 2009 17819 17825
48. J.R. Zabrecky, and M.A. Raftery The role of lipids in the function of the acetylcholine receptor J. Recept. Res. 5 1985 397 417
49. J. Lechleiter, M. Wells, and R. Gruener Halothane-induced changes in acetylcholine receptor channel kinetics are attenuated by cholesterol Biochim. Biophys. Acta 856 1986 640 645
50. J. Santiago, and G.R. Guzmàn J.A. Lasalde-Dominicci Probing the effects of membrane cholesterol in the Torpedo californica acetylcholine receptor and the novel lipid-exposed mutation α C418W in Xenopus oocytes J. Biol. Chem. 276 2001 46523 46532
51. V. Borroni, and C.J. Baier F.J. Barrantes Cholesterol depletion activates rapid internalization of submicron-sized acetylcholine receptor domains at the cell membrane Mol. Membr. Biol. 24 2007 1 15
52. C.A. Báez-Pagán, and Y. Martínez-Ortiz J.A. Lasalde-Dominicci Potential role of caveolin-1-positive domains in the regulation of the acetylcholine receptor's activatable pool: implications in the pathogenesis of a novel congenital myasthenic syndrome Channels (Austin) 2 2008 180 190
53. C.J.B. daCosta, and L. Dey J.E. Baenziger A distinct mechanism for activating uncoupled nicotinic acetylcholine receptors Nat. Chem. Biol. 9 2013 701 707
54. G. Brannigan, and J. Hénin M.L. Klein Embedded cholesterol in the nicotinic acetylcholine receptor Proc. Natl. Acad. Sci. USA 105 2008 14418 14423
55. M.H. Cheng, Y. Xu, and P. Tang Anionic lipid and cholesterol interactions with α4β2 nAChR: insights from MD simulations J. Phys. Chem. B 113 2009 6964 6970
56. D.R. Bristow, and I.L. Martin Solubilisation of the γ-aminobutyric acid/benzodiazepine receptor from rat cerebellum: optimal preservation of the modulatory responses by natural brain lipids J. Neurochem. 49 1987 1386 1393
57. S.M. Dunn, and C.R. Martin R. Miyazaki Functional reconstitution of the bovine brain GABAA receptor from solubilized components Biochemistry 28 1989 2545 2551
58. A receptor to GABA in acutely dissociated rat hippocampal neurones Neuropharmacology 40 2001 178 184
59. A receptors Trends Neurosci. 33 2010 299 306
60. A receptors Brain Res. Brain Res. Rev. 37 2001 91 97
61. A receptors through two discrete transmembrane sites Nature 444 2006 486 489
62. A receptors Pharmacol. Ther. 116 2007 7 19
63. G.-D. Li, and D.C. Chiara R.W. Olsen Neurosteroids allosterically modulate binding of the anesthetic etomidate to γ-aminobutyric acid type A receptors J. Biol. Chem. 284 2009 11771 11775 10.1074/jbc.C900016200
64. A receptor by neuroactive steroids and other potentiators Br. J. Pharmacol. 134 2001 1303 1311
65. J. Krůsek, and H. Zemková Effect of ivermectin on γ-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones Eur. J. Pharmacol. 259 1994 121 128
66. A receptor J. Pharmacol. Exp. Ther. 295 2000 1051 1060
67. A receptor by the insecticide ivermectin Eur. J. Pharmacol. 394 2000 163 170
68. A. Tasneem, and L.M. Iyer L. Aravind Identification of the prokaryotic ligand-gated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels Genome Biol. 6 2005 R4
69. G. Rendon, and M.R. Kantorovitz E. Jakobsson Identifying bacterial and archaeal homologs of pentameric ligand-gated ion channel (pLGIC) family using domain-based and alignment-based approaches Channels (Austin) 5 2011 325 343
70. A receptor comprising agonist and benzodiazepine binding sites PLoS ONE 8 2013 e52323
71. E.J. Bertaccini, and O. Yoluk J.R. Trudell Assessment of homology templates and an anesthetic binding site within the γ-aminobutyric acid receptor Anesthesiology 119 2013 1087 1095 10.1097/ALN.0b013e31829e47e3
72. N. Eswar, and B. Webb A. Sali Comparative protein structure modeling using Modeller Curr. Protoc. Bioinformatics Chapter 5 2007 Unit 5.6
73. E. Schreiner, and L.G. Trabuco K. Schulten Stereochemical errors and their implications for molecular dynamics simulations BMC Bioinformatics 12 2011 190
74. W. Humphrey, A. Dalke, and K. Schulten VMD: visual molecular dynamics J. Mol. Graph. 14 1996 33 38 27-28
75. G.G. Krivov, M.V. Shapovalov, and R.L. Dunbrack Jr. Improved prediction of protein side-chain conformations with SCWRL4 Proteins 77 2009 778 795
76. Q. Chen, and M.H. Cheng P. Tang Anesthetic binding in a pentameric ligand-gated ion channel: GLIC Biophys. J. 99 2010 1801 1809
77. O. Trott, and A.J. Olson AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J. Comput. Chem. 31 2010 455 461
78. E.F. Pettersen, and T.D. Goddard T.E. Ferrin UCSF Chimera - a visualization system for exploratory research and analysis J. Comput. Chem. 25 2004 1605 1612
79. S. Jo, and J.B. Lim W. Im CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes Biophys. J. 97 2009 50 58
80. A.D. MacKerell Jr.; and D. Bashford M. Karplus All-atom empirical potential for molecular modeling and dynamics studies of proteins J. Phys. Chem. B 102 1998 3586 3616
81. A.D. MacKerell Jr.; M. Feig, and C.L. Brooks III Improved treatment of the protein backbone in empirical force fields J. Am. Chem. Soc. 126 2004 698 699
82. J.B. Klauda, and R.M. Venable R.W. Pastor Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types J. Phys. Chem. B 114 2010 7830 7843
83. M.C. Pitman, and F. Suits S.E. Feller Molecular-level organization of saturated and polyunsaturated fatty acids in a phosphatidylcholine bilayer containing cholesterol Biochemistry 43 2004 15318 15328
84. J.B. Lim, B. Rogaski, and J.B. Klauda Update of the cholesterol force field parameters in CHARMM J. Phys. Chem. B 116 2012 203 210
85. J.C. Phillips, and R. Braun K. Schulten Scalable molecular dynamics with NAMD J. Comput. Chem. 26 2005 1781 1802
86. U. Essman, and L. Perela L.G. Pedersen A smooth particle mesh Ewald method J. Chem. Phys. 103 1995 8577 8592
87. O.S. Smart, and J.G. Neduvelil M.S. Sansom HOLE: a program for the analysis of the pore dimensions of ion channel structural models J. Mol. Graph. 14 1996 354 360 376
88. N. Mnatsakanyan, and M. Jansen Experimental determination of the vertical alignment between the second and third transmembrane segments of muscle nicotinic acetylcholine receptors J. Neurochem. 125 2013 843 854
89. A receptor M2 channel-lining segments J. Biol. Chem. 280 2005 35506 35512
90. A and acetylcholine receptor M3 segments J. Neurosci. 26 2006 4492 4499
91. A receptor α1M1-β2M3 transmembrane subunit interface: experimental basis for homology modeling of an intravenous anesthetic binding site J. Neurosci. 29 2009 3083 3092
92. M. Bali, and M.H. Akabas Gating-induced conformational rearrangement of the γ-aminobutyric acid type A receptor β-α subunit interface in the membrane-spanning domain J. Biol. Chem. 287 2012 27762 27770
93. D. Marsh, A. Watts, and F.J. Barrantes Phospholipid chain immobilization and steroid rotational immobilization in acetylcholine receptor-rich membranes from Torpedo marmorata Biochim. Biophys. Acta 645 1981 97 101
94. Q. Shan, J.L. Haddrill, and J.W. Lynch Ivermectin, an unconventional agonist of the glycine receptor chloride channel J. Biol. Chem. 276 2001 12556 12564
95. T. Lynagh, and T.I. Webb J.W. Lynch Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel J. Biol. Chem. 286 2011 43913 43924
96. T. Lynagh, and J.W. Lynch Ivermectin binding sites in human and invertebrate Cys-loop receptors Trends Pharmacol. Sci. 33 2012 432 441
97. R.J. Law, and F.C. Lightstone Modeling neuronal nicotinic and GABA receptors: important interface salt-links and protein dynamics Biophys. J. 97 2009 1586 1594
98. M.A. Hanson, and V. Cherezov R.C. Stevens A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor Structure 16 2008 897 905
99. S. Hiller, and R.G. Garces G. Wagner Solution structure of the integral human membrane protein VDAC-1 in detergent micelles Science 321 2008 1206 1210
100. D.K. Singh, and T.-P. Shentu I. Levitan Cholesterol regulates prokaryotic Kir channel by direct binding to channel protein Biochim. Biophys. Acta 1808 2011 2527 2533
101. A. Rosenhouse-Dantsker, and S. Noskov I. Levitan Identification of novel cholesterol-binding regions in Kir2 channels J. Biol. Chem. 288 2013 31154 31164 10.1074/jbc.M113.496117
102. G. Picazo-Juárez, and S. Romero-Suárez T. Rosenbaum Identification of a binding motif in the S5 helix that confers cholesterol sensitivity to the TRPV1 ion channel J. Biol. Chem. 286 2011 24966 24976 10.1074/jbc.M111.237537
103. P.S. Miller, and T.G. Smart Binding, activation and modulation of Cys-loop receptors Trends Pharmacol. Sci. 31 2010 161 174